Cargando…
Synergistic Signaling of KRAS and Thyroid Hormone Receptor β Mutants Promotes Undifferentiated Thyroid Cancer through MYC Up-Regulation()()
Undifferentiated thyroid carcinoma is one of the most aggressive human cancers with frequent RAS mutations. How mutations of the RAS gene contribute to undifferentiated thyroid cancer remains largely unknown. Mice harboring a potent dominant negative mutant thyroid hormone receptor β, TRβPV (Thrb(PV...
Autores principales: | Zhu, Xuguang, Zhao, Li, Park, Jeong Won, Willingham, Mark C., Cheng, Sheue-yann |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Neoplasia Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4234871/ https://www.ncbi.nlm.nih.gov/pubmed/25246276 http://dx.doi.org/10.1016/j.neo.2014.08.003 |
Ejemplares similares
-
Oncogenic mutations of thyroid hormone receptor β
por: Park, Jeong Won, et al.
Publicado: (2015) -
Synergistic effects of BET and MEK inhibitors promote regression of anaplastic thyroid tumors
por: Zhu, Xuguang, et al.
Publicado: (2018) -
Defective erythropoiesis caused by mutations of the thyroid hormone receptor α gene
por: Park, Sunmi, et al.
Publicado: (2017) -
Src-dependent phosphorylation at Y406 on the thyroid hormone receptor β confers the tumor suppressor activity
por: Park, Jeong Won, et al.
Publicado: (2014) -
Epigenetic Modifications: Novel Therapeutic Approach for Thyroid Cancer
por: Zhu, Xuguang, et al.
Publicado: (2017)